The current spectrum of infection in cancer patients with chemotherapy related neutropenia.
about
Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patientsHow Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future DirectionsNew Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesTherapeutic strategies for chemotherapy-induced neutropenia in patients with solid tumors.Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.Role of lipegfilgrastim in the management of chemotherapy-induced neutropeniaEvaluation of Selected Immunomodulatory Glycoproteins as an Adjunct to Cancer Immunotherapy.Antimicrobial resistance: a global multifaceted phenomenon.Bloodstream infections in neutropenic cancer patients: A practical update.Laboratory Diagnosis of Infections in Cancer Patients: Challenges and Opportunities.Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies.Antibiotic resistance in cancer patients.Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation.Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms.Detection of Legionella Pneumophila in Urine and Serum Specimens of Neutropenic Febrile Patients with Haematological Malignancies.Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.Coccidioidomycosis in Patients with Selected Solid Organ Cancers: A Case Series and Review of Medical Literature.The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center.Short-course daptomycin lock and systemic therapy for catheter-related bloodstream infections: a retrospective cohort study in cancer patients with surgically implanted devices.In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.A new emerging oral infection: Raoultella planticola in a boy with haematological malignancy.Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer.The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center.Bacterial Spectrum, Isolation Sites and Susceptibility Patterns of Pathogens in Adult Febrile Neutropenic Cancer Patients at a Specialist Hospital in Saudi Arabia.Modulating Host Signaling Pathways to Promote Resistance to Infection by Candida albicans.Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014-16).Antimicrobial Resistance Pattern and Spectrum of Multiple-drug-resistant Enterobacteriaceae in Iranian Hospitalized Patients with Cancer.A broad-spectrum antibiotic, DCAP, reduces uropathogenic Escherichia coli infection and enhances vorinostat anticancer activity by modulating autophagy.
P2860
Q26768126-43D2FE43-7F2E-4A2B-A12A-FC7863D537B1Q26771113-8C0B0D05-0554-49A0-8F8F-A97DF42A7092Q26799580-58F83FEA-1BAE-4260-8F55-A2C5723DBBECQ34670717-5F61B281-1C4C-4563-BAE9-D47F5ABB72CAQ34678894-20ACFC38-AB12-4155-9B15-2ABA39FB0560Q35298321-D7B89AA0-62E9-4C8A-BD6E-4EB6E16543F1Q35901088-39B878C5-9E20-4EEC-BD7F-9F8C225C50DEQ36622815-EDFA7EB2-8DB7-4BAD-AA85-03BD2FA7A33BQ36913345-BB4F1BBB-455B-4BE7-9F2C-E736A866AB24Q37363377-1CFC9488-BD6A-4855-AE00-3709D8176765Q37467192-9CC9C779-AA86-4ADC-9802-8A880F7352DDQ38212258-231DF729-86FA-4B85-9DF6-1157E32165A4Q38302802-DEDFA39E-D8DD-4436-8EA8-20F026FEC299Q38538705-06DD23B5-D629-460C-AD50-9AD37DA14762Q38746817-917B438C-94A6-4839-BFFE-8F6519F9E23FQ38747206-FEADDF5C-24CF-4441-9779-1450682A6CE3Q38880522-89B579B7-FACF-4A0C-A7AC-982C221FA6FCQ38918900-3C3EDF4D-A390-4C25-B02E-FD42546A30B5Q38930113-BE749A41-1F39-4717-B284-29DD14219EC6Q39019284-3544E5DE-5308-4F09-9730-B4D4270742D9Q40071896-C29367DD-956B-46C0-81BC-87AB7243A48BQ40252885-5B116EDD-F5E9-44E0-971F-E1B3942A3C74Q40275530-DD3B2897-656D-48C0-BA95-A28C491649A8Q40361152-F93EB27B-C988-4BA7-B373-F4BA31C00AABQ40706134-1D67F93F-5B3A-47D7-820A-B32EB86D7CCAQ40992066-0FED2BE9-818B-42BB-B6C3-0E5499C0B0A6Q45305504-66BE2507-FFAD-445F-A88F-B8B77FDAF6ACQ47334511-80DD55B4-40EC-4CB8-8D08-DDF0E59CCD9EQ52854660-CE60013F-F651-409A-A37E-6257FBF76E7BQ54293201-957C6A06-E451-4E84-9061-AD9A5FDEA1B4Q55115674-3DC263E7-B84C-45AE-97A1-6B6025C6DE44Q55645076-B33CEC65-06E5-4713-B02E-6C4132F082F3
P2860
The current spectrum of infection in cancer patients with chemotherapy related neutropenia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The current spectrum of infect ...... motherapy related neutropenia.
@en
type
label
The current spectrum of infect ...... motherapy related neutropenia.
@en
prefLabel
The current spectrum of infect ...... motherapy related neutropenia.
@en
P2860
P1433
P1476
The current spectrum of infect ...... emotherapy related neutropenia
@en
P2093
Kenneth V I Rolston
P2860
P2888
P356
10.1007/S15010-013-0525-9
P50
P577
2013-08-23T00:00:00Z
P6179
1000105305